报价延迟最少15分钟:2026/05/14 06:48 EDT
盘前时段
|
||||
|
119.37 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
117.38
|
|
|
| 价值评估 |
|
盈利(现时/预测)
7.42/12.27
|
|
企业价值
12.85B
|
| 资产负债 |
|
每股账面净值
122.25
|
| 现金流量 |
|
现金流量率
0.12
|
| 损益表 |
|
收益
1.76B
|
|
每股收益
106.11
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market. |
